Telemonitoring for chronic obstructive pulmonary disease: a cost and cost-utility analysis of a randomised controlled trial

Andrew Stoddart*, Marjon van der Pol, Hilary Pinnock, Janet Hanley, Lucy McCloughan, Allison Todd, Ashma Krishan, Brian McKinstry

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Abstract

We compared the costs and cost-effectiveness of telemonitoring vs usual care for patients with chronic obstructive pulmonary disease (COPD). A total of 256 patients were randomised to either telemonitoring or usual care. In the telemonitoring arm, the touch-screen telemonitoring equipment transmitted data to clinical teams monitoring the patients. Total healthcare costs were estimated over a 12-month period from a National Health Service perspective and quality adjusted life year (QALYs) were estimated by the EQ-5D tool. Telemonitoring was not significantly more costly than usual care (mean difference per patient 2065.90 pound (P

Original languageEnglish
Pages (from-to)108-118
Number of pages11
JournalJournal of Telemedicine and Telecare
Volume21
Issue number2
Early online date13 Jan 2015
DOIs
Publication statusPublished - 1 Mar 2015

Keywords

  • Aged
  • Cost-Benefit Analysis
  • Female
  • Health Care Costs
  • Humans
  • Male
  • Middle Aged
  • Pulmonary Disease, Chronic Obstructive
  • Quality of Life
  • Quality-Adjusted Life Years
  • State Medicine
  • Surveys and Questionnaires
  • Telemedicine
  • United Kingdom
  • Journal Article
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

Fingerprint

Dive into the research topics of 'Telemonitoring for chronic obstructive pulmonary disease: a cost and cost-utility analysis of a randomised controlled trial'. Together they form a unique fingerprint.

Cite this